Schmidt & Clark | A National Law Firm

Levitra Linked to Sudden Vision Loss & Blindness by U.S. Food & Drug Administration

Bookmark | Live Chat

Link to Article: Levitra Linked to Sudden Vision Loss & Blindness by U.S. Food & Drug Administration

Posted in: Non Arteritic Anterior Ischemic Optic Neuropathy, Levitra

Levitra (Vardenafil hydrochloride) has been linked by the U.S. Food & Drug Administration to a serious eye disorder called Non-arteritic anterior ischemic optic neuropathy or NAION.

The FDA is advising patients to “Stop using Levitra if you have a loss in your eyesight. Get medical help right away.”

Non-arteritic anterior ischemic optic neuropathy is a medical condition in which an individual experiences a loss of vision due to blocked blood flow affecting the optic nerve. This blockage can result in permanent damage to the optic nerve and can cause vision loss in one or both eyes. Commonly called a stroke of the eye, NAION affects nearly 8,000 individuals in the United States annually.

Do I have a Levitra Vision Loss or Blindness Lawsuit?

If you or a loved one have taken Levitra and suffered from any sort of vision loss problems, you should contact us immediately. You may be entitled to significant financial compensation for your injuries and we can help.

Levitra Vision Loss & Blindness Lawsuit

 

Free Confidential Case Evaluation

Toll Free 24 hrs/day (866) 588-0600

Secure 128-bit SSL Encrypted Email Communication Secure 128-bit SSL Encrypted Email Communication - Click Here.

Secure 128-bit SSL Encrypted Email Communication Secure 1024-bit SSL Encrypted Live Chat Communication - Click Here.

Fields Marked with * are required= Required Field

Toll Free (866) 588-0600

People Over Profits - Attorney, Lawyer Group

American Association for Justice - Trial Lawyer Group

Peer Review Rated Attorneys and Lawyers

 

 

ATLA Attorney, Atla Lawyer